Related Experiment Video

Updated: Oct 11, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.9K

Therapeutic implications of cancer gene amplifications without mRNA overexpression: silence may not be golden

Amélie Boichard1, Scott M Lippman2, Razelle Kurzrock2,3

  • 1Department of Molecular Cancer Genetics, University of Strasbourg Hospitals, 67000, Strasbourg, France. amelie.boichard@chru-strasbourg.fr.

Journal of Hematology & Oncology
|December 3, 2021
PubMed

Insights

Not all gene amplifications lead to overexpression. Non-focal amplifications, if overexpressed, may be therapeutically tractable, offering new avenues for cancer treatment.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Gene amplifications are key drivers in cancer, often targeted for therapy.
  • Patient response to therapies targeting amplified oncogenes varies, prompting investigation into underlying mechanisms.
  • The relationship between gene copy number and gene expression, particularly for focal versus non-focal amplifications, requires further elucidation.

Discussion:

  • High-level gene amplifications (≥6 copies) do not always result in RNA overexpression.
  • Focal amplifications are unexpectedly more prone to silencing than non-focal amplifications.
  • Non-focal amplifications are frequently overexpressed, suggesting potential therapeutic utility.

Key Insights:

  • Gene amplification does not always equate to gene overexpression.
  • Non-focal amplifications are more consistently overexpressed compared to focal amplifications.
  • Silencing of amplified genes, both focal and non-focal, may contribute to drug resistance.

Outlook:

  • Investigating the mechanisms of gene silencing in amplified regions is crucial.
  • Non-focal amplifications represent a potentially targetable therapeutic window.
  • Understanding gene silencing in amplifications could reveal strategies to overcome drug resistance.
Keywords:
Gene amplificationTherapeutic actionabilitymRNA expression

More Related Videos

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.7K
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K